Comparative study on some systemic humoral and cellular immune markers in only HIV or HIV and hepatitis B infected

C Voiculescu1, M Bălăşoiu, A Turculeanu

  • 1Faculty of Medicine Craiova, Department of Microbiology and Immunology, Craiova, Romania.

Romanian Journal of Virology
|January 1, 1993
PubMed

Insights

Children with co-infection of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) show more severe immune dysfunction than those with HIV alone. Progression to AIDS-related complex (ARC) involves decreased HIV antibodies and increased p24 antigen levels, especially in co-infected individuals.

Area of Science:

  • Pediatric Immunology
  • Viral Co-infections
  • Immunodeficiency

Background:

  • Investigating the impact of co-infection on immune parameters in children.
  • Understanding the progression of human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infections.
  • Assessing immune system changes in asymptomatic children with single or co-infections.

Purpose of the Study:

  • To compare immune system parameters in asymptomatic children with HIV alone versus HIV/HBV co-infection.
  • To evaluate changes in HIV-specific antibodies and p24 antigen levels during the progression to AIDS-related complex (ARC).
  • To explore the diagnostic and predictive value of immune markers in pediatric HIV and HBV infections.

Main Methods:

  • Analysis of immunoglobulin levels and lymphocyte subsets (CD4+, CD8+, CD16+, CD19+) in three groups of children (controls, HIV-infected, HIV/HBV co-infected).
  • Assessment of T lymphocyte responsiveness to phytohaemagglutinin (PHA) and natural killer (NK) cell activity.
  • Monitoring of anti-p24 HIV antibodies, Western Blot (WB) patterns, and free p24 antigen levels in serum samples from patients progressing to ARC.

Main Results:

  • Asymptomatic children with HIV/HBV co-infection exhibited more significant immune disorders compared to those with HIV infection only.
  • Progression to ARC in both HIV and HIV/HBV infected groups was associated with decreased anti-p24 HIV antibodies and increased free p24 antigen.
  • HIV/HBV co-infected patients showed higher levels of p24 antigen compared to HIV-infected patients during ARC progression.

Conclusions:

  • HIV/HBV co-infection exacerbates immune dysfunction in children compared to HIV infection alone.
  • Changes in HIV antibody status and p24 antigen levels are critical indicators of disease progression to ARC.
  • Co-infection status influences the magnitude of viral antigen presence during disease progression, highlighting the need for comprehensive monitoring.